AGLIETTA, Massimo

AGLIETTA, Massimo  

ONCOLOGIA  

Mostra records
Risultati 1 - 20 di 434 (tempo di esecuzione: 0.031 secondi).
Titolo Data di pubblicazione Autore(i) File
153Samarium-EDTMP administration followed by hematopoietic stem cell support for bone metastases in osteosarcoma patients. 2012 Berger M; Grignani G; Giostra A; Ferrari S; Ferraresi V; Tamburini A; Cefalo G; Carnevale-Schianca F; Vassallo E; Picci P; Pagano M; Aglietta M; Pellerito RE; Fagioli F.
28th meeting of the Italian Cancer Society (SIC). New challenges of molecular oncology. 2002 LOLLINI PL; PIEROTTI MA; PASSERINI CG; BANI MR; ZUPI G; AGLIETTA M; ALBINI A
45th annual meeting of the Italian Cancer Society. Bergamo, 9-12 November 2003 2004 GIAVAZZI R; AGLIETTA M; ASTOLFI A; FALANGA A; FUSCO A; LABIANCA R; LOLLINI PL; LOMBARDO C; NATALI PG; PIEROTTI MA; PRESTA M; SANTORO M; TARABOLETTI G; ZUPI G; VECCHIO G
A comparison of two GM-CSF schedules to counteract the granulo-monocytopenia of carboplatin-etoposide chemotherapy. 1995 TAFUTO S ;ABATE G ;D'ANDREA P ;SILVESTRI I ;MARCOLIN P ;VOLTA C ;MONTEVERDE A ;COLOMBI S ;ANDORNO S ;AGLIETTA M
A large-scale study of bone marrow involvement in patients with Hodgkin's lymphoma 2004 LEVIS A; PIETRASANTA D; GODIO L; VITOLO U; CIRAVEGNA G; DI VITO F; GAVAROTTI P; GUGLIELMELLI T; ORSUCCI L; RAVIOLO E; SCALABRINI DR; SALVI F;T ONSO A; AGLIETTA M; BOCCADORO M; GALLAMINI A; SAGLIO G; SCASSA E; GALLO E
A modified Trastuzumab antibody for the immunohistochemical detection of HER-2 overexpression in breast cancer 2005 BUSSOLATI G; MONTEMURRO F; RIGHI L; DONADIO M; AGLIETTA M; SAPINO A
A phase I dose-escalation trial of tremelimumab (CP-675,206) in combination with gemcitabine in chemotherapy-naive patients with metastatic pancreatic cancer. 2014 Aglietta M;Barone C;Sawyer MB;Moore MJ;Miller WH Jr;Bagalà C;Colombi F;Cagnazzo C;Gioeni L;Wang E;Huang B;Fly KD;Leone F
A phase II study of three-weekly docetaxel and weekly trastuzumab in HER2-overexpressing advanced breast cancer 2004 MONTEMURRO F; CHOA G; FAGGIUOLO R; DONADIO M; MINISCHETTI M; DURANDO A; CAPALDI A; VIETTI-RAMUS G; ALABISO O; AGLIETTA M
A phase II trial of sorafenib in relapsed and unresectable high-grade osteosarcoma after failure of standard multimodal therapy: an Italian Sarcoma Group study. 2012 Grignani G; Palmerini E; Dileo P; Asaftei SD; D'Ambrosio L; Pignochino Y; Mercuri M; Picci P; Fagioli F; Casali PG; Ferrari S; Aglietta M.
A pilot study evaluating serum pro-prostate-specific antigen in patients with rising PSA following radical prostatectomy. 2012 Apr 1;3(4):819-824. Epub 2012 Jan 16. PubMed Central PMCID: PMC3362404. 2012 Sottile A; Ortega C; Berruti A; Mangioni M; Saponaro S; Polo A; Prati V; Muto G; Aglietta M; Montemurro F.
A Prospective Phase II Study on Tandem Autografting-Nonmyeloablative Allografting for Newly Diagnosed Myeloma: Final Results of the Gruppo Italiano Trapianto Midollo Osseo. 2007 B. Bruno; M. Rotta; F. Patriarca; D. Mattei; B. Allione; F. Carnevale-Schianca; A. Rambaldi; M. Casini; V. Montefusco; M. Parma; P. Bavaro; F. Onida; A. Busca; L. Castagna; M.P. Iori; D. Maloney; B. Sandmaier; F. Benedetti; N. Mordini; L. Giaccone; R. Sorasio; F. Fiore; A. Filippi; A. Palumbo; M. Aglietta; A. Levis; R. Foà; P. Di Bartolomeo; E. Pogliani; G. Lambertenghi-Deliliers; M. Falda; M. Petrini; P. Corradini; R. Fanin; U. Ricardi; R. Storb; I. Baldi; and Mario Boccadoro
A PROSPECTIVE PHASE II STUDY ON TANDEM AUTOGRAFTING-ONMYELOABLATIVE ALLOGRAFTING FOR NEWLY DIAGNOSED MULTIPLE MYELOMA: FINAL RESULTS OF A MULTICENTER GITMO (GRUPPO ITALIANO TRAPIANTO MIDOLLO OSSEO) PROTOCOL 2007 Sorasio R; Patriarca F; Giaccone L; Mattei D; Allione B; Carnevale-Schianca F; Rambaldi A; Casini M; Montefusco V; Parma M; Bavaro P; Onida F; Busca A; Castagna L; Iori AP; Rotta M; Fiore F; Benedetti E; Mordini N; Massaia M; Palumbo A; Aglietta M; Lewis A; Foà R; Di Bartolomeo P; Pogliani E; Lambertenghi-Deliliers G; Falda M; Petrini M; Corradini P; Fanin R; Ricardi U; Ciccone G; Baldi I; Bruno B; Boccadoro M
Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies 2017 Sanlorenzo, Martina; Vujic, Igor; Floris, Arianna; Novelli, Mauro; Donini, Chiara; Gammaitoni, Loretta; Giraudo, Lidia; Macagno, Marco; Quaglino, Pietro; Fierro, Maria Teresa; Giordano, Silvia; Carnevale-Schianca, Fabrizio; Aglietta, Massimo; Sangiolo, Dario
Abstract LB-366: Everolimus (EV) potentiates Sorafenib (SOR)activity in osteosarcoma (OS) preclinical models: a combination targeting the crosstalk between ERK1/2 and mTORC1/2 signaling pathways 2012 Pignochino, Y.; Dell'Aglio, C.; Basirico, M.; Capozzi, F.; Tarraran, L.; Soster, M.; Marchio, S.; Bruno, S.; Gammaitoni, L.; Sangiolo, D.; D'ambrosio, L.; Picci, P.; Aglietta, M.; Grignani, G.
Activation of JAK2 in human vascular endothelial cells by granulocyte-macrophage colony-stimulating factor. 1997 Soldi R; Primo L; Brizzi MF; Sanavio F; M. Aglietta; Polentarutti N; Pegoraro L; Mantovani A; F. Bussolino
Active immunotherapy in HER2 overexpressing breast cancer: current status and future perspectives. 2013 Milani A;Sangiolo D;Montemurro F;Aglietta M;Valabrega G
Activity of cytokine-induced killer cells against bone and soft tissue sarcoma. 2014 Sangiolo D;Mesiano G;Gammaitoni L;Aglietta M;Grignani G
Acute pulmonary failure after the first administration of recombinant human granulocyte-macrophage colony-stimulating factor. 1992 MINIERO R ;MADON E ;ARTESANI L ;BUSCA A ;SANDRI A ;AGLIETTA M ;RAMENGHI U
Adoptive immunotherapy against ovarian cancer 2016 Mittica, Gloria; Capellero, Sonia; Genta, Sofia; Cagnazzo, Celeste; Aglietta, Massimo; Sangiolo, Dario; Valabrega, Giorgio
Adoptive immunotherapy against sarcomas. 2015 Mesiano G; Leuci V; Giraudo L; Gammaitoni L; Carnevale Schianca F; Cangemi M; Rotolo R; Capellero S; Pignochino Y; Grignani G; Aglietta M; Sangiolo D.